SERMORELIN 5 MG

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE (GHRP)
ACTIVE SUBSTANCE: SERMORELIN
FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER)
ACTIVE HALF-LIFE: 10 TO 20 MINUTES
DOSAGE: MEN 100-300 MCG/DAY
ACNE: RARE
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: SERMORELIN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: ~ 11–12 MINUTES
DOSAGE: 100–300 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: AROMATASE INHIBITOR (AI)
ACTIVE SUBSTANCE: ANASTROZOLE
FORM: 50 TABLETS × 1 MG
ACTIVE HALF-LIFE: ~48 HOURS
DOSAGE: MEN 0.5–1 MG EVERY OTHER DAY
ACNE: REDUCED RISK
WATER RETENTION: PREVENTED
HIGH BLOOD PRESSURE (HBP): LESS LIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: BLOCKED
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS

CLASSIFICATION: ANDROGEN; ANABOLIC STEROID; ANDROGEN ESTER
ACTIVE SUBSTANCE: BOLDENONE UNDECYLENATE
FORM: 10 ML VIAL x 200 MG
ACTIVE HALF-LIFE: 14 DAYS
DOSAGE: MEN 300–600 MG/WEEK
ACNE: RARELY
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: LOW
MANUFACTURER: BRITISH DRAGON PHARMA

CLASSIFICATION: BETA-2 AGONIST (FAT BURNER)
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 TABLETS × 40 MCG
ACTIVE HALF-LIFE: 36–48 HOURS
DOSAGE: MEN 120–140 MCG/DAY, WOMEN 80–100 MCG/DAY
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): POSSIBLE
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS
LABORATORY TESTED: VIEW LAB RESULTS

CLASSIFICATION: ANDROGEN; ANABOLIC STEROID; PROGESTOGEN
ACTIVE SUBSTANCE: NANDROLONE DECANOATE
FORM: 10 ML VIAL x 250 MG
ACTIVE HALF-LIFE: 6-7 DAYS
DOSAGE: MEN 250-500 MG/WEEK
ACNE: RARELY
WATER RETENTION: HIGH
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: LOW
AROMATIZATION: LOW
MANUFACTURER: BRITISH DRAGON PHARMACEUTICALS